Welcome and registration

Part 1: Life Sciences Dealmakers (in collaboration with Kempen)

Plenary session: Keynote by Rudi Pauwels

Coffee Break

Break-out 1: A perfect match: strategically considering licensing and partnerships and what companies look for in deals.

moderated by Hiroshi Sheraton

Panel members:

Andre Hoekema (Galapagos)
Michaël Dillen (Mithra Pharmaceuticals)
Nathalie ter Wengel (Pfizer)
Sijmen de Vries (Pharming)

……………………………………………………………………………………….

Break-out 2: Hot assets: Insights in public investment strategies of life sciences dealmakers.

moderated by Bart Delbaere

Panel members:

Geraldine O’Keeffe (LSP)
Sachin Soni (Third Eye)
Servaas Michielssens (Candriam)

……………………………………………………………………………………….

Break-out 3: It’s term sheet time: How to get the most out of your VC term sheet negotiations.

Moderated by Berthold Hummel

Panel members:

Cedric Ververken (Confo Therapeutics)
Geert-Jan Mulder (Forbion)
Vincent Brichard (Paracrine Biologicals)
Fiona de Hemptinne (UCB Ventures)

Coffee Break

Plenary Session: “The Hot Seat” with Edwin Moses
“From the CEO’s perspective: Building a successful biotech company”

Jan de Kerpel chats with former Ablynx CEO Edwin Moses on the success story of Ablynx under Moses’ reign and the challenges for ambitious biotech companies in today’s healthcare system.

Lunch Break

Part 2: The Future of Healthcare

Plenary Session: Keynote by Lucien Engelen

What’s on the horizon in healthcare? Where are we headed? Influence of AI, data, technology and what that means in practice. For patients, providers and payers. What are the opportunities but also the responsibilities?

Plenary Session: Sustainability: Making your healthcare company future proof

Moderated by Martine van de Laar

Panel members:

Robert Metzke (Philips)
Lieke van Kerkhoven (FLOOW2Healthcare)
Bart van Straten (Van Straten Medical)

Coffee Break

Break-out 1: Regulatory break-out Pharma / Biotech: “The Hot Seat” with Marisa Papaluca (FORMER EMA Senior scientific adviser)

The former Senior Scientific Advisor of the European Medicines Agency (EMA) shares insights on current regulatory challenges.
Moderated by Els Janssens

…………………………………………………………………………………………

Break-out 2: MedTech break-out: Are you ready to navigate today’s MedTech challenges?

Panel discussion on how to deal with new rules and developments in the medtech landscape: e.g., changes in the regulatory framework for IVD and MD, legal aspects of managed services and digital health solutions and legal risk management.
Moderated by Jan Willem Gerritsen

Panel members:

Anne-Sophie Bricca (Terumo BCT Europe N.V.)
Robert Abbott (Stryker)
Oliver Bisazza (MedTech Europe)

Coffee Break

Plenary Session: The next big thing: Hot trends and hurdles in healthcare AI

Moderated by Wouter Seinen

Panel members:

Mark-Jan Harte (Aidence)
Lucien Engelen (Transform.Health / Center for the Edge Deloitte)
Jacco Keja (IQVIA)
Dr. Jaap Bonjer (Amsterdam University Medical Centre)

Drinks and Canapés